| Literature DB >> 33021057 |
Marlena V Habal1,2, April M I Miller1,3, Samhita Rao1, Sijie Lin1,4, Aleksandar Obradovic1, Mohsen Khosravi-Maharlooei1, Sarah B See1, Poulomi Roy1, Ronzon Shihab1, Siu-Hong Ho1,5, Charles C Marboe6, Yoshifumi Naka7, Koji Takeda7, Susan Restaino2, Arnold Han1, Donna Mancini8, Michael Givertz9, Joren C Madsen10,11, Megan Sykes1, Linda J Addonizio12, Maryjane A Farr2, Emmanuel Zorn1.
Abstract
T cells are implicated in the pathogenesis of cardiac allograft vasculopathy (CAV), yet their clonality, specificity, and function are incompletely defined. Here we used T cell receptor β chain (TCRB) sequencing to study the T cell repertoire in the coronary artery, endomyocardium, and peripheral blood at the time of retransplant in four cases of CAV and compared it to the immunoglobulin heavy chain variable region (IGHV) repertoire from the same samples. High-dimensional flow cytometry coupled with single-cell PCR was also used to define the T cell phenotype. Extensive overlap was observed between intragraft and blood TCRBs in all cases, a finding supported by robust quantitative diversity metrics. In contrast, blood and graft IGHV repertoires from the same samples showed minimal overlap. Coronary infiltrates included CD4+ and CD8+ memory T cells expressing inflammatory (IFNγ, TNFα) and profibrotic (TGFβ) cytokines. These were distinguishable from the peripheral blood based on memory, activation, and tissue residency markers (CD45RO, CTLA-4, and CD69). Importantly, high-frequency rearrangements were traced back to endomyocardial biopsies (2-6 years prior). Comparison with four HLA-mismatched blood donors revealed a repertoire of shared TCRBs, including a subset of recently described cross-reactive sequences. These findings provide supportive evidence for an active local intragraft bystander T cell response in late-stage CAV.Entities:
Keywords: T cell biology; basic (laboratory) research/science; coronary artery disease; heart (allograft) function/dysfunction; heart transplantation/cardiology; molecular biology; rejection: vascular
Mesh:
Year: 2020 PMID: 33021057 PMCID: PMC8672660 DOI: 10.1111/ajt.16333
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086